REBTORFA Trademark

Trademark Overview


On Wednesday, September 14, 2022, a trademark application was filed for REBTORFA with the United States Patent and Trademark Office. The USPTO has given the REBTORFA trademark a serial number of 97590989. The federal status of this trademark filing is REGISTERED as of Tuesday, October 17, 2023. This trademark is owned by Glaxo Group Limited. The REBTORFA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
rebtorfa

General Information


Serial Number97590989
Word MarkREBTORFA
Filing DateWednesday, September 14, 2022
Status700 - REGISTERED
Status DateTuesday, October 17, 2023
Registration Number7194990
Registration DateTuesday, October 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Tuesday, October 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 17, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 26, 2023ASSIGNED TO EXAMINER
Thursday, September 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 17, 2022NEW APPLICATION ENTERED